Global health-tech innovator Oneview Healthcare (ASX:ONE) secured $19 million through an upsized two-tranche placement.
The placement, which received robust support from both existing shareholders and international institutional investors, involves the issuance of 100 million new CHESS Depositary Interests priced at $0.19 each.
This represents a 7% discount to the company's last closing price on March 13.
The capital raising is structured to ensure immediate liquidity while maintaining major stakeholder alignment.
The first tranche aims to raise $12 million under existing listing rules, with settlement expected by March 24.
The second tranche, a $7 million commitment from the company's largest shareholder, Manderrah (trustee of the GJJ Family Trust), remains subject to shareholder approval at an extraordinary general meeting scheduled for May.
Beyond the institutional placement, Oneview is extending an invitation to its retail base through a share purchase plan.
Eligible security holders in Australia, New Zealand, and Ireland can subscribe for up to $30,000 of new CDIs at the same $0.19 price point, targeting an additional $2 million.
Management intends to deploy the proceeds to fortify the balance sheet and accelerate the rollout of "Ovie," the company's new AI-powered virtual patient assistant.